The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations.

Ghaffarpour, Nader; Baselga, Eulalia; Boon, Laurence M; Diociaiuti, Andrea; Dompmartin, Anne; Dvorakova, Veronika; El Hachem, May; Gasparella, Paolo; Haxhija, Emir; Kyrklund, Kristiina; Irvine, Alan D; Kapp, Friedrich G; Rössler, Jochen; Salminen, Päivi; van den Bosch, Caroline; van der Vleuten, Carine; Kool, Leo Schultze; Vikkula, Miikka (2022). The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations. European journal of medical genetics, 65(12), p. 104637. Elsevier 10.1016/j.ejmg.2022.104637

[img]
Preview
Text
1-s2.0-S176972122200218X-main.pdf - Accepted Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Lymphatic malformations (LMs) are developmental defects of lymphatic vessels. LMs are histologically benign lesions, however, due to localization, size, and unexpected swelling, they may cause serious complications that threaten vital functions such as compression of the airways. A large swelling of the face or neck may also be disfiguring and thus constitute a psychological strain for patients and their families. LMs are also highly immunologically reactive, and are prone to recurrent infections and inflammation causing pain as well as chronic oozing wounds. The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) is dedicated to gathering the best expertise in Europe. There are only few available guidelines on management and follow up of LMs, which commonly focus on very specific situations, such as head and neck LM (Zhou et al., 2011). It is still unclear, what constitutes an indication for treatment of LMs and how to follow up the patients. The Vascular Anomalies Working Group (VASCA-WG) of VASCERN decided to develop a diagnostic and management pathway for the management of LMs with a Nominal Group Technique (NGT), a well-established, structured, multistep, facilitated group meeting technique used to generate consensus statements. The pathway was drawn following 2 face-to-face meetings and multiple web meetings to facilitate discussion, and by mail to avoid the influence of most authoritative members. The VASCA-WG has produced this opinion statement reflecting strategies developed by experts and patient representatives on how to approach patients with lymphatic malformations in a practical manner; we present an algorithmic view of the results of our work.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Haematology/Oncology

UniBE Contributor:

Rössler, Jochen Karl

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1878-0849

Publisher:

Elsevier

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

13 Oct 2022 14:42

Last Modified:

29 Aug 2023 12:39

Publisher DOI:

10.1016/j.ejmg.2022.104637

PubMed ID:

36223836

Uncontrolled Keywords:

Alpelisib Interventional radiology Lymphatic malformation Management PIK3CA Patient pathway Sclerotherapy Sirolimus Surgery Treatment algorithm Vascular malformation

BORIS DOI:

10.48350/173698

URI:

https://boris.unibe.ch/id/eprint/173698

Actions (login required)

Edit item Edit item
Provide Feedback